Clinical Trial Update: Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating oral hymecromone for treating adolescents and adults with primary sclerosing cholangitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Hymecromone (hymecromone)

Snippet

Sponsor: Aparna Goel | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: RECRUITING